DexCom, Inc. (DXCM)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
Today 5:13 PM
View: 
Doubleday Richard
Sr. VP. Worldwide Sales
DexCom, Inc. (DXCM) Yesterday Market Option Sale (Planned) 4,000$43.58$174,310.00(3%)
123.95K to 119.95K
(1%)
Today 5:12 PM
View: 
Pacelli Steven Robert
EVP, Strategy & Corp. Dev.
DexCom, Inc. (DXCM) Yesterday Option Exercise 14,000$7.63$106,820.006%
228.87K to 242.87K
Today 5:12 PM
View: 
Pacelli Steven Robert
EVP, Strategy & Corp. Dev.
DexCom, Inc. (DXCM) Yesterday Market Option Sale (Planned) 14,000$43.60$610,449.00(6%)
242.87K to 228.87K
(1%)
Today 5:13 PM
View: 
Doubleday Richard
Sr. VP. Worldwide Sales
DexCom, Inc. (DXCM) Yesterday Option Exercise 4,000$6.03$24,120.003%
119.95K to 123.95K
21-Oct-14 7:53 PM
View: 
Roper Jess
VP, CFO
DexCom, Inc. (DXCM) 20-Oct-14Option Exercise 8,000$7.63$61,040.0010%
83.34K to 91.34K
21-Oct-14 7:53 PM
View: 
Roper Jess
VP, CFO
DexCom, Inc. (DXCM) 20-Oct-14Market Option Sale (Planned) 8,000$41.18$329,463.00(9%)
91.34K to 83.34K
(2%)
16-Oct-14 8:02 PM
View: 
Gregg Terrance H
CEO
Director
DexCom, Inc. (DXCM) 15-Oct-14Market Sale (Planned) 10,000$39.63$396,277.00(< 1%)
1.04M to 1.03M
(5%)
16-Oct-14 8:02 PM
View: 
Gregg Terrance H
CEO
Director
DexCom, Inc. (DXCM) 15-Oct-14Option Exercise 25,000$6.85$171,250.002%
1.04M to 1.06M
16-Oct-14 8:02 PM
View: 
Gregg Terrance H
CEO
Director
DexCom, Inc. (DXCM) 15-Oct-14Market Option Sale (Planned) 25,000$39.63$990,692.00(2%)
1.06M to 1.04M
(5%)
14-Oct-14 6:05 PM
View: 
Balo Andrew K
SVP, Regulatory and Clinical
DexCom, Inc. (DXCM) 13-Oct-14Market Option Sale (Planned) 10,000$40.42$404,165.00(6%)
160.13K to 150.13K
(< 1%)
14-Oct-14 6:21 PM
View: 
Lister John
Sr. VP, General Counsel
DexCom, Inc. (DXCM) 13-Oct-14Market Sale (Planned) 1,650$40.41$66,681.90(1%)
110.33K to 108.67K
(< 1%)
14-Oct-14 6:21 PM
View: 
Lister John
Sr. VP, General Counsel
DexCom, Inc. (DXCM) 13-Oct-14Option Exercise 1,750$4.58$8,015.002%
110.33K to 112.08K
14-Oct-14 6:05 PM
View: 
Balo Andrew K
SVP, Regulatory and Clinical
DexCom, Inc. (DXCM) 13-Oct-14Option Exercise 10,000$7.63$76,300.007%
150.13K to 160.13K
14-Oct-14 6:21 PM
View: 
Lister John
Sr. VP, General Counsel
DexCom, Inc. (DXCM) 13-Oct-14Market Option Sale (Planned) 1,750$40.41$70,723.20(2%)
112.08K to 110.33K
(< 1%)
10-Oct-14 5:09 PM
View: 
Valdes Jorge A
CTO
DexCom, Inc. (DXCM) 08-Oct-14Option Exercise 16,000$7.25$116,000.008%
194.28K to 210.28K
10-Oct-14 5:09 PM
View: 
Valdes Jorge A
CTO
DexCom, Inc. (DXCM) 08-Oct-14Market Option Sale (Planned) 16,000$40.29$644,651.00(8%)
210.28K to 194.28K
(< 1%)
25-Sep-14 8:30 PM
View: 
Balo Andrew K
SVP, Regulatory and Clinical
DexCom, Inc. (DXCM) 25-Sep-14Option Exercise 10,000$7.63$76,300.007%
150.13K to 160.13K
25-Sep-14 8:30 PM
View: 
Balo Andrew K
SVP, Regulatory and Clinical
DexCom, Inc. (DXCM) 25-Sep-14Market Option Sale (Planned) 10,000$40.71$407,072.00(6%)
160.13K to 150.13K
(2%)
24-Sep-14 6:43 PM
View: 
Doubleday Richard
Sr. VP. Worldwide Sales
DexCom, Inc. (DXCM) 23-Sep-14Option Exercise 4,000$6.03$24,120.003%
119.95K to 123.95K
24-Sep-14 6:43 PM
View: 
Doubleday Richard
Sr. VP. Worldwide Sales
DexCom, Inc. (DXCM) 23-Sep-14Market Option Sale (Planned) 4,000$40.32$161,262.00(3%)
123.95K to 119.95K
(< 1%)
24-Sep-14 6:42 PM
View: 
Pacelli Steven Robert
EVP, Strategy & Corp. Dev.
DexCom, Inc. (DXCM) 23-Sep-14Option Exercise 14,000$7.63$106,820.006%
228.87K to 242.87K
24-Sep-14 6:42 PM
View: 
Pacelli Steven Robert
EVP, Strategy & Corp. Dev.
DexCom, Inc. (DXCM) 23-Sep-14Market Option Sale (Planned) 14,000$40.32$564,483.00(6%)
242.87K to 228.87K
(< 1%)
18-Sep-14 6:38 PM
View: 
Roper Jess
VP, CFO
DexCom, Inc. (DXCM) 18-Sep-14Market Option Sale (Planned) 8,000$41.91$335,306.00(9%)
91.34K to 83.34K
< 1%
18-Sep-14 6:38 PM
View: 
Roper Jess
VP, CFO
DexCom, Inc. (DXCM) 18-Sep-14Option Exercise 8,000$7.68$61,440.0010%
83.34K to 91.34K
15-Sep-14 8:57 PM
View: 
Lister John
Sr. VP, General Counsel
DexCom, Inc. (DXCM) 15-Sep-14Option Exercise 5,500$4.58$25,190.005%
104.83K to 110.33K
17-Sep-14 6:59 PM
View: 
Gregg Terrance H
CEO
Director
DexCom, Inc. (DXCM) 15-Sep-14Market Sale (Planned) 10,000$41.14$411,422.00(< 1%)
1.05M to 1.04M
< 1%
17-Sep-14 6:59 PM
View: 
Gregg Terrance H
CEO
Director
DexCom, Inc. (DXCM) 15-Sep-14Option Exercise 25,000$6.85$171,250.002%
1.05M to 1.07M
17-Sep-14 6:59 PM
View: 
Gregg Terrance H
CEO
Director
DexCom, Inc. (DXCM) 15-Sep-14Market Option Sale (Planned) 25,000$41.14$1,028,560.00(2%)
1.07M to 1.05M
< 1%
15-Sep-14 8:57 PM
View: 
Lister John
Sr. VP, General Counsel
DexCom, Inc. (DXCM) 12-Sep-14Disposition 3,083$43.36$133,686.00(3%)
111.43K to 108.34K
2%
15-Sep-14 7:46 PM
View: 
Balo Andrew K
SVP, Regulatory and Clinical
DexCom, Inc. (DXCM) 12-Sep-14Disposition 4,404$43.36$190,968.00(3%)
154.53K to 150.13K
2%
15-Sep-14 8:57 PM
View: 
Lister John
Sr. VP, General Counsel
DexCom, Inc. (DXCM) 12-Sep-14Market Option Sale (Planned) 3,518$43.70$153,739.00(3%)
108.34K to 104.83K
3%
15-Sep-14 8:06 PM
View: 
Roper Jess
VP, CFO
DexCom, Inc. (DXCM) 12-Sep-14Disposition 2,643$43.36$114,607.00(3%)
85.98K to 83.34K
2%
15-Sep-14 7:45 PM
View: 
Pacelli Steven Robert
EVP, Strategy & Corp. Dev.
DexCom, Inc. (DXCM) 12-Sep-14Disposition 6,308$43.36$273,530.00(3%)
235.17K to 228.87K
2%
15-Sep-14 8:51 PM
View: 
Valdes Jorge A
CTO
DexCom, Inc. (DXCM) 12-Sep-14Disposition (other) 11,936$43.36$517,574.00(6%)
206.22K to 194.28K
2%
15-Sep-14 8:57 PM
View: 
Lister John
Sr. VP, General Counsel
DexCom, Inc. (DXCM) 12-Sep-14Option Exercise 1,750$4.58$8,015.002%
109.68K to 111.43K
15-Sep-14 7:45 PM
View: 
Doubleday Richard
Sr. VP. Worldwide Sales
DexCom, Inc. (DXCM) 12-Sep-14Disposition 4,404$43.36$190,968.00(4%)
124.35K to 119.95K
2%
15-Sep-14 8:06 PM
View: 
Sayer Kevin R
President & COO
Director
DexCom, Inc. (DXCM) 12-Sep-14Disposition 13,211$43.36$572,861.00(3%)
414.06K to 400.85K
2%
16-Sep-14 6:54 PM
View: 
Moy Jeffrey
SVP, Operations
DexCom, Inc. (DXCM) 12-Sep-14Gift 650----(< 1%)
236.37K to 235.72K
15-Sep-14 8:51 PM
View: 
Valdes Jorge A
CTO
DexCom, Inc. (DXCM) 12-Sep-14Disposition
Duplicate
6,308$43.36$273,530.00(3%)
212.53K to 206.22K
2%
15-Sep-14 8:51 PM
View: 
Valdes Jorge A
CTO
DexCom, Inc. (DXCM) 12-Sep-14Acquisition (other) 11,936$43.36$517,574.006%
200.59K to 212.53K
(2%)
12-Sep-14 8:02 PM
View: 
Balo Andrew K
SVP, Regulatory and Clinical
DexCom, Inc. (DXCM) 11-Sep-14Option Exercise 10,000$7.63$76,300.006%
154.53K to 164.53K
12-Sep-14 9:43 PM
View: 
Moy Jeffrey
SVP, Operations
DexCom, Inc. (DXCM) 11-Sep-14Disposition 4,404$43.36$190,968.00(2%)
240.78K to 236.37K
(< 1%)
12-Sep-14 8:02 PM
View: 
Balo Andrew K
SVP, Regulatory and Clinical
DexCom, Inc. (DXCM) 11-Sep-14Market Option Sale (Planned) 10,000$42.97$429,706.00(6%)
164.53K to 154.53K
(2%)
12-Sep-14 9:43 PM
View: 
Moy Jeffrey
SVP, Operations
DexCom, Inc. (DXCM) 11-Sep-14Grant 8,333$43.36$361,339.004%
232.44K to 240.78K
< 1%
12-Sep-14 9:43 PM
View: 
Moy Jeffrey
SVP, Operations
DexCom, Inc. (DXCM) 10-Sep-14Disposition 3,802$43.23$164,368.00(2%)
236.25K to 232.44K
(1%)
15-Sep-14 8:51 PM
View: 
Valdes Jorge A
CTO
DexCom, Inc. (DXCM) 10-Sep-14Acquisition (other) 11,937$43.23$516,062.006%
206.82K to 218.75K
(2%)
12-Sep-14 8:51 PM
View: 
Doubleday Richard
Sr. VP. Worldwide Sales
DexCom, Inc. (DXCM) 10-Sep-14Disposition 2,228$43.23$96,321.10(2%)
126.58K to 124.35K
(1%)
12-Sep-14 8:44 PM
View: 
Sayer Kevin R
President & COO
Director
DexCom, Inc. (DXCM) 10-Sep-14Disposition 10,861$43.23$469,544.00(3%)
424.92K to 414.06K
(1%)
12-Sep-14 9:43 PM
View: 
Moy Jeffrey
SVP, Operations
DexCom, Inc. (DXCM) 10-Sep-14Grant 7,291$43.23$315,196.003%
228.95K to 236.25K
1%
15-Sep-14 8:51 PM
View: 
Valdes Jorge A
CTO
DexCom, Inc. (DXCM) 10-Sep-14Disposition
Duplicate
6,225$43.23$269,120.00(3%)
218.75K to 212.53K
2%